Affordable Insulin for All
Project Insulin is a nonprofit drug company fixing a broken system. We’re not researching a novel drug; we’re removing the barriers that make an old one inaccessible by developing & manufacturing insulin ourselves and selling it at cost.
Access to insulin is not a scientific problem.
It's a money problem.
Insulin is 100+ years old, yet people still can’t afford it.
Insulin costs force 1 in 5 users in America to ration their supply. Just 3 manufacturers dominate 90% of the market. Project Insulin exists to disrupt this system by providing affordable, reliable insulin directly to the people who need it most.
Insulin is 100+ years old, yet people still can’t afford it.
Insulin costs force 1 in 5 users in America to ration their supply. Just 3 manufacturers dominate 90% of the market. Project Insulin exists to disrupt this system by providing affordable, reliable insulin directly to the people who need it most.
How We’ll Make It
We’re developing our own biosimilar (generic) insulin glargine, through partnerships with contract research and manufacturing organizations. By owning our insulin we will control the price patients pay.
How We’ll Get Approved
How We'll Deliver It
How We’re Funding it
You help ensure no one has to ration insulin
We’re done waiting for others to solve this problem.
We need your help to fund development, purification and testing of affordable insulin. Join our effort to make insulin accessible and sustainable for all who rely on it.
Accountable
to people,
not profits.
The system is broken.
As a nonprofit, our duty is to patients, not shareholders. Every decision aims to get insulin to those who need it. We stay transparent in development, manufacturing, and delivery. Our mission is to make insulin affordable and accessible to everyone.
Read our latest news
Frequently Asked Questions
Why is Insulin so expensive?
Insulin prices are high because three companies dominate the market and a complicated web of middlemen makes distributing insulin convoluted and expensive. Pharmacy benefit managers, insurers, and wholesalers all add costs. The result is a system where patients often pay hundreds of dollars for a vial of insulin that costs only a fraction of that to make.